JPRN-jRCTs051210131进行中（未招募）3 期
Randomized double blinded phase II trial of midazolam and midazolam / fentanyl combined in endobronchial ultrasonic-guided transbronchial needle aspiration (EBUS-TBNA) (KURM007) - midazolam / fentanyl in EBUS-TBNA
Tachihara Motoko0 个研究点目标入组 98 人开始时间: 2021年12月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) over20 years old
- •(2) EBUS-TBNA is scheduled to be performed for the purpose of biopsy of mediastinal lesions.
- •(3) Document consent can be obtained by the patient regarding participation in this study
排除标准
- •(1) drug hypersensitivity constitution such as allergies to the drugs used in this study.
- •(2) Have acute narrow-angle glaucoma
- •(3) Have myasthenia gravis
- •(4) Have uncontrollable bronchial asthma
- •(5) Being in a spastic state
- •(6) Taking HIV protease inhibitor or nalmefene
- •(7) The use of muscle relaxants is contraindicated
- •(8) Prone to respiratory depression such as coma due to head injury, brain tumor, etc.
- •(9) Taking opioids
- •(10) Others who are judged to be inappropriate by the person in charge of this test
研究者
相似试验
进行中（未招募）
1 期
PPALM - Palm oil and Pentoxifylline Against Late MorbidityAdverse effects of radiotherapy for pelvic cancer.EUCTR2012-004211-31-GBThe Royal Marsden NHS Foundation Trust62
进行中（未招募）
2 期
Sotagliflozin in patients with heart failure symptoms and type 1 diabetesType 1 Diabetes, Heart FailureNutritional, Metabolic, EndocrineISRCTN79322795niversity of Dundee320
尚未招募
2 期
INFINiTE-CV2 Phase IIa Trial: INterFeron type 1 Intra-Nasal gel Therapy for Early treatment of SARS-CoV2 (COVID-19)ACTRN12622000258752IntraVital100
进行中（未招募）
不适用
Maintenance therapy in patients with platinum-sensitive advanced non-small cell lung cancerAdvanced non-small cell lung cancerMedDRA version: 18.0Level: LLTClassification code 10025052Term: Lung cancer non-small cell stage IIISystem Organ Class: 100000004864MedDRA version: 18.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864EUCTR2014-005586-75-ESGustave Roussy500
招募中
2 期
Randomized, double-blinded Phase-II-trial with Docetaxel + Sorafenib (Nexavar®) versus Docetaxel + Placebo as firstline treatment for patients with HER2/neu-negative metastasized cancer of the breast.C50Malignant neoplasm of breastDRKS00003947niversitätsklinikum Heidelberg288